Neural stem cells (NSCs) produce all neuronal subtypes involved in the nervous system. The mechanism regulating their subtype selection is not fully understood. We found that the expression of the nucleotide receptor P2Y4 was transiently augmented in the course of neuronal differentiation of mouse embryonic stem cells (ESCs), which was after loss of pluripotency but prior to terminal differentiation of neurons. The activation of P2Y4 in the differentiating ESCs resulted in an increased proportion of neurons expressing vesicular glutamate transporter (vGluT), a marker of glutamatergic subtype. A subpopulation of type 2 NSCs of the adult mouse hippocampus expressed P2Y4. Its activation induced the expression of glutamatergic subtype markers, vGluT and TBR1, in their descendant neurons. Reciprocally, inhibition of the P2Y4 signaling abolished the effects of nucleotides on those expressions. Our results provide evidence that differentiating NSCs pass through a stage in which nucleotides can affect subtype marker expression of their descendant neurons.
INTRODUCTION
The brain contains many different subtypes of neurons, such as dopaminergic, GABAergic, cholinergic, and glutamatergic neurons. All neurons are differentiated from neural stem cells (NSCs). The mechanism by which NSCs produce such variety of neuronal subtypes is not fully understood.
Glutamatergic neurons are the most abundant subtype in the mammalian brain (Fonnum, 1984) . Production of this neuronal subtype can be observed not only in the development of the forebrain but also throughout life in the hippocampus of the adult brain (Gage, 2000) . In the development, glutamatergic neurons are produced from neuroepithelial cells at the dorsal side of the anterior neural tube, but GABAergic neurons are produced at the ventral side (Danesin et al., 2009) . For this patterning along the dorsoventral axis, Sonic hedgehog (SHH) and WNT are the determinant factors for ventral and dorsal characters of cells, respectively. The canonical WNT signaling through b-catenin induces expression of a transcription factor, PAX6 (Gan et al., 2014) , activating the cascade of transcription factors including TBR1 and TBR2 for glutamatergic neuronal differentiation (Backman et al., 2005; Hevner et al., 2006; Machon et al., 2007) .
In the adult hippocampus, stem cells located at the subgranular zone (SGZ) can produce neurons throughout life (Ming and Song, 2005) . Radial glial cell-type NSCs expressing glial fibrillary acidic protein (GFAP) are called type 1 in the SGZ (Kempermann et al., 2004) . Type 1 NSCs develop into post-mitotic neurons through three consecutive stages of progenitor cells, namely types 2a, 2b, and 3. The majority of newborn neurons in the SGZ matures into glutamatergic granule neurons in the hippocampus. The signaling pathways triggering glutamatergic subtype selection in the adult hippocampus are not fully understood.
Many studies have provided evidence that signaling initiated from extracellular nucleotides plays important roles in the regulation of neurogenesis not only during embryonic development of the brain but also in the adult brain (Neary and Zimmermann, 2009; Zimmermann, 2011) . Extracellular nucleotides can activate ionotropic receptors (P2X1-7) and G-protein-coupled receptors (P2Y1, 2, 4, 6, 8, 11-14) (Erb et al., 2006) . While all P2X receptors are activated by ATP, the agonist specificity of P2Y receptors is dependent upon their subtype (von Kugelgen, 2006) . For instance, P2Y1 is activated by both ATP and ADP but not uridine triphosphate (UTP), whereas P2Y2 is activated by both ATP and UTP but not ADP. In vitro experiments indicated that ATP and/or UTP can stimulate proliferation and survival of NSCs (Mishra et al., 2006; Lin et al., 2007; Milosevic et al., 2006) . In vivo, ATP secreted from astrocytes regulates proliferation of NSCs in the adult hippocampus (Cao et al., 2013) . These reports indicate that extracellular nucleotides can control proliferation of NSCs. However, the effects of extracellular nucleotides on selection of neuronal subtypes have not been elucidated. In the present study, we found that extracellular nucleotides can induce glutamatergic subtype neuronal markers through the activation of P2Y4 nucleotide receptor.
RESULTS

ATP Induces Expression of Vesicular Glutamate Transporter
The differentiation of mouse embryonic stem cells (ESCs) was induced by depletion of fibroblast growth factor 2 (FGF2) and epidermal growth factor (EGF), either with or without ATP addition. Neurons expressing a glutamatergic subtype marker vesicular glutamate transporter (vGluT) were observed abundantly in the neurons differentiated in the presence of added ATP ( Figures 1A and S1 ). Without ATP addition, the majority of differentiated neuronal cells expressed vesicular g-aminobutyric acid (GABA) transporter (vGAT), a marker of GABAergic neurons. Neither expression of a dopaminergic subtype marker tyrosine hydroxylase nor of a cholinergic subtype marker vesicular acetylcholine transporter was detectable under these conditions. The addition of ATP had no detectable effects on the expression of a neuronal marker tubulin-bIII ( Figures 1B and 1C) . Compared with the cells differentiated in the absence of ATP addition, expression of vGAT and vGluT in cells differentiated in the presence of ATP addition was 2-fold lower and higher, respectively ( Figure 1D ). Thus, ATP induces expression of a glutamatergic subtype marker vGluT.
Nucleotide Specificity of vGluT Induction
To examine which receptor mediates the ATP-induced vGluT expression, we added nucleotides separately to the medium of differentiating ESCs. ATP can activate P2Xs and P2Ys; however, UTP can activate only P2Y2 and P2Y4 (von Kugelgen, 2006) . The added triphosphate form of nucleotides can be digested into di-or monophosphate form in the culture medium, and uridine diphosphate (UDP) is a specific agonist of P2Y6 (von Kugelgen, 2006) . Both ATP and UTP, but not UDP, induced expression of vGluT in neurons differentiated from mouse ESCs (Figures 2A and 2B ). This suggests that P2Y2 and/or P2Y4 are involved in the induction of vGluT expression ( Figure S2 ). Figure 2C shows expression of P2Y2 and P2Y4 in the differentiation of ESCs. While P2Y2 expression was not changed during the differentiation, P2Y4 expression was transiently increased (Figures 2C and 2D ). P2Y4 expression peaked on day 4 of differentiation, and the expression level on day 8 of differentiation was similar to that on day 0. Expression of a pluripotent marker, Oct4, was suddenly decreased after the induction of differentiation, and was almost absent by day 4 of differentiation ( Figure 2E ). Expression of an immature neuron marker, tubulin-bIII, was obvious from day 6 of differentiation. These results suggest that expression of P2Y4 is increased transiently during differentiation, and that its peak occurs after loss of pluripotency but before the terminal differentiation of neurons.
To examine when extracellular nucleotides can induce vGluT expression, we added ATP to the medium of differentiating mouse ESCs from day 0, 3, 5, or 7 of differentiation. Treatment with ATP from day 0, day 3, and day 5 increased expression of vGluT in the descendant neurons (Figures 2F Figure S1 . and 2G). Induction of vGluT expression was almost absent when the cells were treated with ATP from day 7 of differentiation. Treatment with ATP from days 3 to 7 of differentiation was sufficient to induce vGluT expression in the descendant neurons. When ATP was not added, ESCs differentiated into neurons expressing vGAT ( Figure 2F , control). These results indicate that the window of nucleotide-mediated vGluT expression is from day 3 to day 7 of the neuronal differentiation of ESCs, which is coincident with the increased P2Y4 expression.
Expression of P2Y4 in Hippocampus NSCs
To examine P2Y4 expression in NSCs further, we used NSCs prepared from the postnatal mouse hippocampus. NSCs in the hippocampus are classified into four types, types 1, 2a, 2b, and 3, by their profiles of protein expression. One of five NSC clones derived from the hippocampus (clone d) showed higher expression of P2Y4 than the others (Figure 3A) . Cells expressing GFAP, a marker of type 1 NSCs, were abundant in the clone c NSCs but not in the clone d NSCs ( Figure 3B ). SRY-related HMG-box gene 2 (SOX2) is a stem cell marker expressed mainly in types 1 and 2 NSCs (von Bohlen und Halbach, 2011). Expression of SOX2 was detected in almost all cells derived from the adult mouse hippocampus ( Figure 3B ). Cells in the clones a, b, and e also show expression of GFAP and SOX2 similar to that of the clone c. These results suggest that NSCs derived from the hippocampus are types 1 and 2, and that the difference in P2Y4 expression among those NSC clones could be due to cell types of NSCs.
Less than approximately 10% of GFAP-positive cells expressed P2Y4 in clone d NSCs ( Figures 3C and 3D ). Nestin is expressed in types 1 and 2 NSCs (Kempermann et al., 2004; von Bohlen und Halbach, 2011) . Approximately 60% of nestin-positive cells expressed P2Y4. P2Y4 was frequently co-expressed with doublecortin, a marker of type 2b NSCs (Kempermann et al., 2004; von Bohlen und Halbach, 2011) . Figure 3E shows the expression of P2Y4 in the sections prepared from adult mouse hippocampus. P2Y4-Positive cells were observed sparsely in the SGZ of the adult mouse hippocampus. Expression of either nestin or doublecortin, but not GFAP, was frequently observed in the P2Y4-positive cells ( Figures 3E and 3F ). These results suggest that P2Y4 is expressed in type 2 NSCs of the adult hippocampus.
Signaling from P2Y4 Induces Expression of Glutamatergic Neuronal Markers Although NSCs in the hippocampus produce glutamatergic neurons in vivo, neurons differentiated from the NSCs in vitro were mainly vGAT positive ( Figure 4A, control) . The addition of UTP, a P2Y4 agonist, promoted production of neurons expressing vGluT ( Figure 4A, UTP) . The glutamatergic neuron-specific transcription factor TBR1 exhibited nuclear location when differentiation was induced in the presence of added UTP (Figures 4B and 4C ). These results suggest that production of glutamatergic neurons is not intrinsic to hippocampus NSCs, but appears to be dependent upon the microenvironment around the differentiating NSCs in the hippocampus. Moreover, these results indicate that UTP can promote expression of glutamatergic neuronal markers in newborn neurons differentiated from NSCs derived from the hippocampus.
To assess the effects of P2Y4 depletion on the expression of glutamatergic subtype markers, we transfected small interfering RNAs (siRNAs) into the clone d cells. Transfection of siRNAs against P2Y4 and Gq-a decreased the expression levels of those target proteins, respectively (Figures 4D and 4E) , and the siRNAs inhibited UTP-dependent induction of glutamatergic neurons ( Figures 4F and 4G ). These results indicate that the P2Y4-Gq signaling axis has a crucial role in nucleotide-dependent induction of the glutamatergic neuronal markers.
DISCUSSION
The neuronal network in the brain is constructed of many different subtypes of neurons; however, the mechanism by which NSCs produce a variety of neuronal subtypes is not fully understood. In this study, we show that UTP treatment of differentiating NSCs derived from the postnatal mouse hippocampus induced expression of glutamatergic neuron markers, vGluT and TBR1, in their descendant neurons. Nucleotide-induced vGluT expression was also observed in the neuronal differentiation of mouse ESCs. Uracil nucleotides, both UTP and UDP, have been reported to promote dopaminergic differentiation of NSCs derived from the human fetal midbrain (Milosevic et al., 2006) . Delic and Zimmermann (2010) showed that 2ClATP, but not uracil nucleotides, promotes dopaminergic differentiation of NSCs derived from the ventral mesencephalon of embryonic day 10.5 (E10.5) and E13.5 mice. Nucleotide receptors corresponding to this induction of dopaminergic neurons have not been identified. Taking these reports and the present study together, the effects of extracellular nucleotides appear to be variable and are perhaps dependent upon region and developmental stage of tissues used for NSC preparation.
The present study indicated that induction of glutamatergic markers by nucleotides involved the P2Y4-Gq signaling axis. Expression of the P2Y4 nucleotide receptor was transiently augmented in the course of neuronal differentiation of ESCs, which is coincident with the window of nucleotide-induced vGluT expression. P2Y4 expression was observed in type 2 NSCs of the adult mouse (legend continued on next page) hippocampus, mainly in type 2b. In vitro experiments indicated that activation of the P2Y4 expressed in the type 2 NSCs was sufficient for induction of glutamatergic markers in their descendant neurons. Since the decision regarding neuronal cell fate is thought to occur in the early stage of type 2 NSCs (Kempermann et al., 2004) , the differentiation stage sensitive to the nucleotide-induced glutamatergic subtype selection appears to follow the decision of the neuronal lineage, but precedes terminal differentiation of neurons. Thus far, some in vitro methods for induction of glutamatergic neuron subtype have been reported (Reyes et al., 2008; Gaspard et al., 2008; Shi et al., 2012) ; however, it remains uncertain which stage of differentiating NSCs is sensitive to these induction methods. The present study indicated a differentiation stage in which expression of neuronal subtype markers can be affected by extracellular nucleotides.
In summary, this study demonstrated that differentiating NSCs transiently expressed a nucleotide receptor P2Y4. P2Y4 was co-expressed with type 2 NSC markers, doublecortin and nestin, in the SGZ of adult mouse hippocampus. Activation of P2Y4 in NSCs resulted in expression of glutamatergic neuronal markers in descendant neurons. Taken together, these results suggest that NSCs differentiating into neurons pass through a stage in which nucleotides can affect the expression of subtype markers of descendant neurons.
EXPERIMENTAL PROCEDURES Antibodies
Anti-mouse P2Y4 (ab180718), anti-nestin (ab134017), anti-doublecortin (ab135349), and anti-TBR1 (ab31904) antibodies were purchased from Abcam. Anti-tubulin b III antibody (T5076) was purchased from Sigma. Anti-vGAT antibody (131003) was purchased from Synaptic Systems. Anti-P2Y2 antibody (PA1-4517) was purchased from Thermo. Anti-OCT4 antibody (611203) was purchased from BD Bioscience. Anti-mouse vGluT (MAB5502), anti-GFAP (AB5541), anti-SOX2 (AB5603), anti-Gq-a (06-709) antibodies were purchased from Millipore.
Mouse ESC Culture and Differentiation Induction
The mouse ESC line CGR8 was maintained in ESGRO Complete Plus medium (Millipore) on gelatin-coated dishes. For induction of differentiation, the cells were seeded at a density of 1 3 10 4 cells/cm 2 in RHB-A medium (Takara) on gelatin-coated ibidi micro-dishes (Ying et al., 2003) . Half of the medium was changed every day. For treatment with nucleotides, RHB-A medium containing 20 mM of the indicated nucleotide was used.
Mouse Adult NSC Preparation, Culture, and Differentiation
All animals were handled and cared for in accordance with the Guide of Care and Use of Laboratory Animals approved by the Ethic Committee of Experimental Animals of Kyoto University. Mouse NSCs were prepared from the hippocampus of the postnatal day 5 Balb/c mouse. For preparation of single-cell suspensions from tissues, Nerve-Cells Dispersion Solution (Sumitomo Bakelite) was used. For isolation of NSCs, neurospheres were prepared using the NeuroCult NCFC Assay Kit (Stem Cell Technology). Neurospheres with a diameter of 1-2 mm were isolated after 3 weeks of incubation and dispersed with Accutase (Millipore) to prepare a single-cell suspension. This neurosphere formation process was repeated twice. For monolayer culture of NSCs, single-cell suspension was seeded on dishes coated with polyornithine and laminin in N2B27 medium containing 0.1 mg/ml heparin, 20 ng/ml FGF2, and 20 ng/ml EGF. For neuronal differentiation, cells were seeded on ibidi microdishes (35 mm) coated with polyornithine and laminin in N2B27 media containing 0.1 mg/ml heparin, 20 ng/ml FGF2, and 20 ng/ml EGF. After incubation for 2 days, the medium was changed to N2B27 medium lacking heparin and the growth factors. Half of the medium was changed every day. For treatment with nucleotide, N2B27 medium containing 20 mM of the indicated nucleotide was used.
Immunofluorescence of Cells
Cells were fixed with 2% paraformaldehyde and immunofluorescence was performed as described previously (Takei, 2009) 
Preparation of Brain Slices from Adult Mice and Immunofluorescence
All animals were handled and cared for in accordance with the Guide for the Care and Use of Laboratory Animals approved by the Ethics Committee of Experimental Animals of Kyoto University. Male C57BL/6 mice, 7 weeks old, under deep anesthesia with isoflurane were transcardially perfused with PBS followed by 4% paraformaldehyde (PFA) in PBS. Brains were removed and (F) ATP was added to the medium of differentiating mouse ESCs at a final concentration of 20 mM for the indicated days. (G) Cells positive for vGAT or vGluT in (F) were quantified as described in Experimental Procedures. The graph shows the mean of three independent experiments and the error bars indicate SE. *p < 0.05 relative to control (Student's t test). See also Figure S2 . 
Preparation of Cell Extracts and Western Blotting
Cells were harvested and washed once with PBS. Cell pellets were resuspended in a 4-fold volume of 20 mM Tris-HCl (pH 8.0), 
Transfection of siRNA
NeuroMag (OZ Bioscience) was used to introduce siRNAs into NSCs according to the manufacturer's recommendations.
RT-PCR
Total RNA was prepared from cultured NSCs using Isogen reagent and Direct-Zol (Zymogen), and used for cDNA synthesis with Superscript II (Invitrogen). cDNA prepared from 250 ng of RNA was used as the template for PCR. The sequence of the forward primer for mouse P2Y4 was AGACGGGCCTGATGTGTATC and the reverse was AGGTTCACATGCCCTGTACC. 
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